8 unchanged sentences
333-254534), filed with the SEC on March 19, 2021).
−Removed: Sales Agreement, dated May 2, 2022, by and between the Registrant and SVB Securities LLC (incorporated by reference to Exhibit 1.2 to the Registrant’s Registration Statement on Form S-3 (File No.
−Removed: 333-264616), filed with the SEC on May 2, 2022).
−Removed: Letter Agreement by and between the Registrant and Roshawn Blunt, dated August 2, 2022.
+Added: Letter Agreement by and between the Registrant and Roshawn Blunt, dated August 2, 2022 (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q, filed with the SEC on August 9, 2022).
+Added: Reneo Pharmaceuticals, Inc.
+Added: Severance Benefit Plan, as amended as of September 27, 2022, and form of Participation Agreement thereunder.
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
17 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: August 9, 2022
+Added: November 8, 2022
RENEO PHARMACEUTICALS, INC.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.